Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;36(1):e24064.
doi: 10.1002/jcla.24064. Epub 2021 Nov 16.

Hematological changes associated with COVID-19 infection

Enass Abdul Kareem Dagher Al-Saadi  1 , Marwa Ali Abdulnabi  2
Affiliations
Review

Hematological changes associated with COVID-19 infection

Enass Abdul Kareem Dagher Al-Saadi et al. J Clin Lab Anal. 2022 Jan.

Abstract

Background: The unresolved COVID-19 pandemic considerably impacts the health services in Iraq and worldwide. Consecutive waves of mutated virus increased virus spread and further constrained health systems. Although molecular identification of the virus by polymerase chain reaction is the only recommended method in diagnosing COVID-19 infection, radiological, biochemical, and hematological studies are substantially important in risk stratification, patient follow-up, and outcome prediction.

Aim: This narrative review summarized the hematological changes including the blood indices, coagulative indicators, and other associated biochemical laboratory markers in different stages of COVID-19 infection, highlighting the diagnostic and prognostic significance.

Methods: Literature search was conducted for multiple combinations of different hematological tests and manifestations with novel COVID-19 using the following key words: "hematological," "complete blood count," "lymphopenia," "blood indices," "markers" "platelet" OR "thrombocytopenia" AND "COVID-19," "coronavirus2019," "2019-nCoV," OR "SARS-CoV-2." Articles written in the English language and conducted on human samples between December 2019 and January 2021 were included.

Results: Hematological changes are not reported in asymptomatic or presymptomatic COVID-19 patients. In nonsevere cases, hematological changes are subtle, included mainly lymphocytopenia (80.4%). In severe, critically ill patients and those with cytokine storm, neutrophilia, lymphocytopenia, elevated D-dimer, prolonged PT, and reduced fibrinogen are predictors of disease progression and adverse outcome.

Conclusion: Monitoring hematological changes in patients with COVID-19 can predict patients needing additional care and stratify the risk for severe course of the disease. More studies are required in Iraq to reflect the hematological changes in COVID-19 as compared to global data.

Keywords: CBC; COVID-19; coagulopathy; hematology.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Khandait H, Gandotra G, Sachdeva S, et al. COVID‐19 and hematology—what do we know so far? SN Compr Clin Med. 2020;2(12):2631‐2636. - PMC - PubMed
    1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus‐infected pneumonia. N Engl J Med. 2020;382:1199‐1207. - PMC - PubMed
    1. European Centre for Disease Prevention and Control COVID‐19 situation update worldwide: European Centre for Disease Prevention and Control; 2020. https://www.ecdc.europa.eu/en/about‐ecdc. Accessed November 11, 2020.
    1. Dawood AA, Dawood ZAJV. How will the second wave of the dreadful COVID‐19 be with the increasing number of the infected cases and mortality in Iraq? Vacunas. 2021;22(2):114‐118. - PMC - PubMed
    1. MEDBOX worldometer‐COVID19: MEDBOX 2020 [cited 2021 April]. https://www.worldometers.info/coronavirus/country/iraq/. Accessed November 11, 2020.